CN100342894C - A Chinese medicine for treating liver disease - Google Patents
A Chinese medicine for treating liver disease Download PDFInfo
- Publication number
- CN100342894C CN100342894C CNB2005100415335A CN200510041533A CN100342894C CN 100342894 C CN100342894 C CN 100342894C CN B2005100415335 A CNB2005100415335 A CN B2005100415335A CN 200510041533 A CN200510041533 A CN 200510041533A CN 100342894 C CN100342894 C CN 100342894C
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- gram
- liver
- parched
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 26
- 208000019423 liver disease Diseases 0.000 title claims abstract description 18
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 12
- 241000411851 herbal medicine Species 0.000 claims abstract description 8
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 8
- 241000756943 Codonopsis Species 0.000 claims description 13
- 241000180649 Panax notoginseng Species 0.000 claims description 10
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 10
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 10
- 239000010231 banlangen Substances 0.000 claims description 9
- 210000004185 liver Anatomy 0.000 abstract description 16
- 230000001737 promoting effect Effects 0.000 abstract description 12
- 210000004369 blood Anatomy 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 9
- 208000019425 cirrhosis of liver Diseases 0.000 abstract description 9
- 230000006870 function Effects 0.000 abstract description 8
- 208000002672 hepatitis B Diseases 0.000 abstract description 8
- 210000000952 spleen Anatomy 0.000 abstract description 8
- 206010003445 Ascites Diseases 0.000 abstract description 7
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 235000013399 edible fruits Nutrition 0.000 abstract description 4
- 230000003908 liver function Effects 0.000 abstract description 4
- 241000334160 Isatis Species 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 240000007772 Anthriscus sylvestris Species 0.000 abstract 1
- 235000005749 Anthriscus sylvestris Nutrition 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 abstract 1
- 240000005717 Dioscorea alata Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241000123889 Rubus chingii Species 0.000 abstract 1
- 241000304432 Sedum sarmentosum Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 210000000941 bile Anatomy 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 230000003950 pathogenic mechanism Effects 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 13
- 239000000796 flavoring agent Substances 0.000 description 11
- 235000019634 flavors Nutrition 0.000 description 11
- 208000006454 hepatitis Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 231100000283 hepatitis Toxicity 0.000 description 9
- 230000002440 hepatic effect Effects 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 230000036407 pain Effects 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 3
- 244000192528 Chrysanthemum parthenium Species 0.000 description 3
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 229920001202 Inulin Polymers 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000000994 depressogenic effect Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 235000008384 feverfew Nutrition 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 3
- 229940029339 inulin Drugs 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- TYPSVDGIQAOBAD-DZGCQCFKSA-N Atractylone Chemical compound C([C@]1(C)C2)CCC(=C)[C@@H]1CC1=C2OC=C1C TYPSVDGIQAOBAD-DZGCQCFKSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 244000283207 Indigofera tinctoria Species 0.000 description 2
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- -1 acetyl pachymic acid Chemical compound 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 230000035568 catharsis Effects 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229940097275 indigo Drugs 0.000 description 2
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- JXDYKVIHCLTXOP-UHFFFAOYSA-N isatin Chemical compound C1=CC=C2C(=O)C(=O)NC2=C1 JXDYKVIHCLTXOP-UHFFFAOYSA-N 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- JVXZRQGOGOXCEC-UHFFFAOYSA-N scutellarein Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C(O)=C(O)C=C2O1 JVXZRQGOGOXCEC-UHFFFAOYSA-N 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 102000014898 transaminase activity proteins Human genes 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- XWMMEBCFHUKHEX-MRTCRTFGSA-N (+)-Taraxasterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C XWMMEBCFHUKHEX-MRTCRTFGSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- QMKPCZNFLUQTJZ-UHFFFAOYSA-N (4aR)-10c-Hydroxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen Natural products CC1CCC2(C)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C QMKPCZNFLUQTJZ-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 206010009208 Cirrhosis alcoholic Diseases 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 235000000228 Citrus myrtifolia Nutrition 0.000 description 1
- 235000016646 Citrus taiwanica Nutrition 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000220284 Crassulaceae Species 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 241000234272 Dioscoreaceae Species 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- 208000024283 Gingival haemorrhages Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 206010019728 Hepatitis alcoholic Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000124449 Paeonia obovata Species 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010036018 Pollakiuria Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 241001618264 Rubus coreanus Species 0.000 description 1
- 244000272264 Saussurea lappa Species 0.000 description 1
- 235000006784 Saussurea lappa Nutrition 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 208000002353 alcoholic hepatitis Diseases 0.000 description 1
- 208000010002 alcoholic liver cirrhosis Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- TYPSVDGIQAOBAD-UHFFFAOYSA-N atractylone Natural products C1C2(C)CCCC(=C)C2CC2=C1OC=C2C TYPSVDGIQAOBAD-UHFFFAOYSA-N 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000002850 nasal mucosa Anatomy 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- VDYCLYGKCGVBHN-UHFFFAOYSA-N pachymaic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC(=C)C(C)C)C(O)=O)C(O)CC21C VDYCLYGKCGVBHN-UHFFFAOYSA-N 0.000 description 1
- SRDNLMOBFKJOSD-UHFFFAOYSA-N pachymic acid Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C(O)=O)C(O)CC21C SRDNLMOBFKJOSD-UHFFFAOYSA-N 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- NGFFRJBGMSPDMS-UHFFFAOYSA-N psi-Taraxasterol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(C)=CCC3(C)CCC21C NGFFRJBGMSPDMS-UHFFFAOYSA-N 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- HUTYZQWCTWWXND-NCTFTGAASA-N taraxasterol Natural products C[C@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(C)CCC1=C HUTYZQWCTWWXND-NCTFTGAASA-N 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese medicine for treating liver diseases, which is prepared from the following Chinese herbal medicines in proportion: 260 to 350g of radix codonopsitis, 50 to 120g of anthriscus sylvestris, 260 to 340g of stir-fired largehead atractylodes rhizome, 350 to 550g of poria from Yunnan of China, 20 to 50g of stir-fired immature orange fruit, 20 to 30g of common aucklandia root, 120 to 220g of common yam rhizome, 180 to 220g of palmleaf raspberry fruit, 150 to 260g of stringy stonecrop herb, 150 to 260g of isatis root, 100 to 220g of dandelion, 300 to 500g of red peony root, 250 to 300g of stir-baked Radix Paeoniae Alba and 40 to 60g of bupleurum root. According to the pathogenic mechanism of hepatosis, the present invention adopts a traditional Chinese medicinal prescription which can mainly replenish qi to invigorate the spleen, supplement the liver and the kidney, disperse stagnated liver qi for promoting bile flow and activate blood circulation to dissipate blood stasis, thereby realizing the functions of adjusting and increasing the immunizing power of organisms, improving the liver functions and making hepatosis stabilized, improved and cured. The prescription of the present invention takes the principle of protecting the liver, and has obvious therapeutic effect on various kinds of hepatosis, particularly on chronic hepatitis B, liver cirrhosis and hepatogenic ascites.
Description
Affiliated technical field
The present invention relates to a kind of medicine for the treatment of hepatopathy, exactly, is a kind of Chinese medicine for the treatment of hepatopathys such as viral hepatitis, liver cirrhosis, hepatic ascites.
Background technology
Hepatitis is as the term suggests be exactly that inflammatory reaction has taken place liver.Because the inner impercipience nerve of liver so pain is not too serious, if check that through " liver living tissue's puncture " hepatic tissue section that obtains is placed on microscopically and sees, can see that there is leukocyte infiltration in the inflammation district.The symptom of hepatitis mainly shows as, heating, weak, inappetence, feel sick, abdominal distention, diarrhoea, yellowish urine, skin and sclera (white of the eye) jaundice, the hepatic region is uncomfortable or pain etc.Chronic hepatitis has that nasal mucosa is hemorrhage, gingival hemorrhage, both legs swelling.Hepatitis gravis can occur that listlessness is depressed, dysphoria, sleep inversion, stupor etc.Hepatitis is commonly encountered diseases, frequently-occurring disease.Be divided into first type virus (HAV) hepatitis, B virus (HBV) hepatitis and third type virus (HCV) hepatitis etc. by morbidity cause virus, wherein, the hepatitis B incidence is the most serious.According to the statistics made by the departments concerned, China hepatitis B patient has 3,000 ten thousand at present, and hepatitis B virus carriers is 1.2 hundred million.Along with the quickening of people's rhythm of life, exceedingly drink, cause the alcoholic hepatitis sickness rate to increase, and ethanol not only can quicken chronic hepatitis such as hepatitis B greatly and changes into the process of liver cirrhosis, and can make healthy people directly drink into alcoholic cirrhosis, or cause hepatocarcinoma.Bad living habit and use medicine improperly causes the hepatitis due to medicine sickness rate also constantly to rise.
The doctor trained in Western medicine hepatopathy is normally checked what index was implemented to treat according to liver.With the treatment hepatitis B is example, and doctor trained in Western medicine is reducing serum alanine aminotransferase, and catharsis has harmful effect to liver but fall the enzyme medicine mostly, and the transaminase can rebound after the drug withdrawal, as re-uses and fall the enzyme medicine and then can cause the catharsis function of liver further to be destroyed.The patient who has paddy acyl transaminase rising can occur after using and falling the enzyme medicine, or bilirubin value seriously raises, hepatic fibrosis occurring is the liver cirrhosis omen, in this case, the enzyme medicine falls if continue to use doctor trained in Western medicine, liver function is made the matter worse beyond doubt, finally may cause liver cirrhosis, hepatic ascites even cancerate.To liver cirrhosis, hepatic ascites disease, doctor trained in Western medicine adopts diuretic or instillation albumin therapy usually, but general curative effect is not good enough, and the expense costliness.
Summary of the invention
For overcoming the defective of existing liver disease method, through exploring for many years, the present invention discloses a kind of easy to use, Chinese prescription that therapeutic effect is good, and the technical solution adopted for the present invention to solve the technical problems is:
1, it is to be made by the Chinese herbal medicine of following consumption proportion:
The 260-350 of Radix codonopsis pilosulae (Radix Codonopsis) gram, GUANG Radix Notoginseng 50-120 gram, Rhizoma Atractylodis Macrocephalae (parched) 260-340 gram, PORIA from Yunnan of China 350-550 gram, Fructus Aurantii Immaturus (parched) 20-50 gram, Radix Aucklandiae 20-30 gram, Rhizoma dioscoreae 120-220 gram, Fructus Rubi 180-220 gram, Herba Sedi Sarmentosi 150-260 gram, Radix Isatidis 150-260 gram, Herba Taraxaci 100-220 gram, Radix Paeoniae Rubra 300-500 gram, Radix Paeoniae Alba (parched) 250-300 gram, Radix Bupleuri 40-60 gram.
2, its optimization prescription is the Chinese herbal medicine by following consumption proportion:
Radix codonopsis pilosulae's 300 grams, GUANG Radix Notoginseng 100 grams, Rhizoma Atractylodis Macrocephalae (parched) 300 grams, PORIA from Yunnan of China 500 grams, Fructus Aurantii Immaturus (parched) 50 grams, the Radix Aucklandiae 30 grams, Rhizoma dioscoreae 200 grams, Fructus Rubi 200 grams, Herba Sedi Sarmentosi 200 grams, Radix Isatidis 200 grams, Herba Taraxaci 200 grams, Radix Paeoniae Rubra 400 grams, Radix Paeoniae Alba (parched) 300 grams, Radix Bupleuri 60 grams.
Chinese medicine of the present invention is traditional honeyed pill, and the Chinese herbal medicine of above-mentioned prescription is ground into superfine powder, the mixing of sieving, and refined honey is made.
The present invention be directed to the hepatopathy pathogeny, selected prescription is based on replenishing QI to invigorate the spleen, liver and kidney tonifying, depressed liver-energy dispersing and function of gallbladder promoting, blood circulation promoting and blood stasis dispelling, reaches to adjust to improve body immunity, improve liver function, makes hepatopathy stable good then control.
The present invention selects Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Rhizoma Dioscoreae, Fructus Rubi, Poria for use, is monarch drug, replenishing QI to invigorate the spleen, liver and kidney tonifying, wherein:
Radix Codonopsis is the root of campanulaceae plant Radix Codonopsis, contain Saponin, alkaloid, sucrose, glucose, inulin, starch, mucus and resin etc., Radix codonopsis pilosulae (Radix Codonopsis) contains volatile oil, scutellarein glucosid, micro-alkaloid, polysaccharide, inulin, Saponin, and nature and flavor are sweet, flat, has invigorating middle warmer, QI invigorating, an effect of promoting the production of body fluid.
The Rhizoma Atractylodis Macrocephalae is a feverfew Rhizoma Atractylodis Macrocephalae rhizome, contains volatile oil, atractylol, atractylone, vitamin etc., and property bitter but sweet flavor, temperature have spleen reinforcing, stomach reinforcing, dampness and middle effect.
Fructus Rubi is green fruits such as rosaceous plant Fructus Rubi, rubus coreanus, contain organic acid, saccharide and a small amount of vitamin C, the sweet acid of nature and flavor, flat has invigorating the liver and kidney, urine reducing, supporing yang, controlling nocturnal emission with astringent drugs, the effect that makes eye bright are controlled diseases such as sexual impotence, seminal emission, frequency of micturition, asthenia, order be dark.
Rhizoma Dioscoreae has another name called RHIIZOMA DIOSCOREAE frOm Henan of China, Rhizoma dioscoreae, tuber for Dioscoreaceae plant Rhizoma Dioscoreae, contain Saponin, phlegmatic temperament, choline, starch, glycoprotein and free amino acid etc., have spleen invigorating, tonifying the lung, reinforce the kidney, beneficial smart function, control diarrhea due to hypofunction of the spleen, chronic dysentery, cough due to consumptive disease, quench one's thirst, seminal emission, leukorrhagia, frequent micturition.
Poria is the dry sclerotia of Polyporaceae plant Poria, contain pachyman, acetyl pachymic acid, natural gum, chitin etc., the property slightly sweet flavor, flat, have eliminating dampness and diuresis, strengthening the spleen stomach function regulating, mind tranquilizing and the heart calming effect, diseases such as controlling dysuria, edema distension, phlegm retention cough with dyspnea, have loose bowels, drench worm, be forgetful.
It is ministerial drug that the present invention selects Radix Notoginseng for use, blood circulation promoting and blood stasis dispelling and the absurd row of not hyperamization, because:
Radix Notoginseng is the root of Araliaceae Panax pseudoginseng, contains Saponin, arasaponin and glucose etc., and property sweet and slightly bitter taste, temperature have hemostasis, dissipating blood stasis, detumescence, analgesic therapy function, controls haematemesis, hemoptysis, has blood in stool, disease such as traumatic hemorrhage, carbuncle pain.
It is adjuvant drug that the present invention selects Fructus Aurantii Immaturus, the Radix Aucklandiae, Radix Paeoniae for use, and Fructus Aurantii Immaturus, the circulation of qi promoting of the broken knot of the Radix Aucklandiae to separate the fraud that causes abdominal distention of qi-benefiting and spleen-strengthening drug, help the merit of Poria circulation of qi promoting diuresis, and the Radix Paeoniae Rubra removing heat from blood and promoting blood circulation helps the Radix Notoginseng blood stasis dispelling, helps the Herba Artemisiae Scopariae function of gallbladder promoting to fall Huang, wherein:
Fructus Aurantii Immaturus is the young fruit of cloud savoury herb Fructus Ponciri Trifoliatae (Fructus Ponciri Trifoliatae Immaturus), Citrus aurantium Linn. or fragrant circle, contains volatile oil, and contains flavonoid glycoside more, and the nature and flavor bitter cold has dispelling the stagnated QI, diffusing painful abdominal mass, rushes down expectorant, removing food stagnancy effect, controls diseases such as distension and fullness of the chest and abdomen, the thoracic obstruction, accumulation of phlegm in the hypochondrium, edema, food stagnation, constipation.
The Radix Aucklandiae is the root of feverfew Saussurea lappa Clarke, vladimiria denticulata Ling, Radix Vladimiriae etc., contains volatile oil, and nature and flavor are arduous, warm, have promoting the circulation of QI to relieve pain, warming middle-JIAO for easing the stomach effect, controls the invasion by pathogenic cold stagnation of QI, chest and abdomen swelling and pain, vomits, has loose bowels etc.
Radix Paeoniae Rubra is the root of the wild Radix Paeoniae of ranunculaceae plant, Paeonia obovata Maxim., river Radix Paeoniae Rubra etc., contains paeoniflorin, and nature and flavor are bitter, flat, have clots absorbing, pain relieving, removing heat from blood, detumescence effect.
It is messenger drug that the present invention selects Herba Sedi Sarmentosi, Radix Isatidis, Herba Taraxaci, Radix Bupleuri for use, and liver heat removing is fallen enzyme and protected stomach, wherein:
Herba Sedi Sarmentosi is the herb of Crassulaceae plant Herba Sedi, and property slightly sweet flavor, cold have heat clearing away, detumescence, detoxicating functions, control laryngopharynx swelling and pain, carbuncle, burn due to hot liquid or fire, Serpentis, insect bite etc.
Radix Isatidis is root or the acanthaceous vegetable acanthaceous indigo rhizome and the root of cruciferae isatis and careless Folium Isatidis, contain indigo glycoside, sitosterol, isatin etc., nature and flavor hardship, cold has heat clearing away, detoxifcation, removing heat from blood effect, controls influenza, encephalitis b, pneumonia, erysipelas, pyretic toxicity and sends out diseases such as speckle, pharyngalgia, skin ulcer rash.
Herba Taraxaci is the whole herb with root of feverfew Herba Taraxaci, contains taraxasterol, choline, inulin and pectin, and property bitter but sweet flavor, cold has heat-clearing and toxic substances removing, diuresis mass-dissipating efficacy, diseases such as treatment carbuncle toxin, cat fever, gastritis, hepatitis, cholecystitis.
Radix Bupleuri is the root of samphire Radix Bupleuri, Radix Bupeuri Scorzonerfolii. etc., contain volatile oil, bupleurumol, oleic acid, linolenic acid, glucose, saikoside etc., nature and flavor hardship, cold have reconciling superficies and interior, soothing the liver, yang invigorating effect, control alternate attack of chill and fever, fullness in the chest costalgia, bitter taste deafness, malaria etc.
The obtained beneficial effect of the present invention is:
1, the present invention is according to the pathogeny of hepatopathy, the Chinese prescription that adopts, and it is main having replenishing QI to invigorate the spleen, liver and kidney tonifying, depressed liver-energy dispersing and function of gallbladder promoting, blood circulation promoting and blood stasis dispelling, reaches to adjust to improve body immunity, improve liver function, makes hepatopathy stable good then control.
2, prescription of the present invention is a principle to protect the liver, and specially the treating the liver disease is applied widely, and various hepatopathys especially chronic viral hepatitis B, liver cirrhosis and hepatic ascites are had obvious curative effects;
3, result of use of the present invention:
Clinical treatment 680 routine hepatopaths with screening are example, hepatitis B patient 520 examples wherein, liver cirrhosis 90 examples, hepatic ascites 70 examples.Using method: the present invention is made honeyed pill, and for oral administration, lunch and supper were taken in last hour, and it is a course of treatment that chronic viral hepatitis B is taken 30 days continuously; It is a course of treatment that liver cirrhosis is taken 30 days; It is a course of treatment that hepatic ascites takes 35.Above-mentioned patient by age reaches the state of an illness and uses the present invention to treat one or two course of treatment continuously, carries out observation of curative effect.408 routine patients recovery from illness is arranged, and follow up a case by regular visits to after 1 year and there is no the recidivist, 68 examples have significant curative effect, and 102 examples have certain curative effect, invalid 102 examples, and total effective rate reaches 85.0%, and cure rate reaches 60%.
The specific embodiment
Below in conjunction with embodiment the present invention is further described.
Embodiment 1:
Take off the row raw material: Radix codonopsis pilosulae's 300 grams, GUANG Radix Notoginseng 100 grams, Rhizoma Atractylodis Macrocephalae (parched) 300 grams, PORIA from Yunnan of China 500 grams, Fructus Aurantii Immaturus (parched) 50 grams, the Radix Aucklandiae 30 grams, Rhizoma dioscoreae 200 grams, Fructus Rubi 200 grams, Herba Sedi Sarmentosi 200 grams, Radix Isatidis 200 grams, Herba Taraxaci 200 grams, Radix Paeoniae Rubra 400 grams, Radix Paeoniae Alba (parched) 300 grams, Radix Bupleuri 60 grams are ground into superfine powder respectively, sieving is mixed, and makes honeyed pill in 1: 1 ratio and refined honey, and the bottling sealing is stand-by.
Embodiment 2:
The Chinese medicine for oral administration of present embodiment is to be made by the Chinese herbal medicine of following consumption proportion: get Radix codonopsis pilosulae's 350 grams, GUANG Radix Notoginseng 120 grams, Rhizoma Atractylodis Macrocephalae (parched) 340 grams, PORIA from Yunnan of China 550 grams, Fructus Aurantii Immaturus (parched) 50 grams, the Radix Aucklandiae 30 grams, Rhizoma dioscoreae 220 grams, Fructus Rubi 220 grams, Herba Sedi Sarmentosi 260 grams, Radix Isatidis 260 grams, Herba Taraxaci 220 grams, Radix Paeoniae Rubra 500 grams, Radix Paeoniae Alba (parched) 300,60 parts of Radix Bupleuri, its preparation method is with embodiment 1.
Embodiment 3:
The Chinese medicine for oral administration of present embodiment is to be made by the Chinese herbal medicine of following consumption proportion: Radix Codonopsis 260 grams, GUANG Radix Notoginseng 50 grams, Rhizoma Atractylodis Macrocephalae (parched) 260 grams, PORIA from Yunnan of China 350 grams, Fructus Aurantii Immaturus (parched) 20 grams, the Radix Aucklandiae 20 grams, Rhizoma dioscoreae 120 grams, Fructus Rubi 180 grams, Herba Sedi Sarmentosi 150 grams, Radix Isatidis 150 grams, Herba Taraxaci 100 grams, Radix Paeoniae Rubra 300 grams, Radix Paeoniae Alba (parched) 250 grams, Radix Bupleuri 40 grams, its preparation method is with embodiment 1.
Claims (2)
1, a kind of Chinese medicine for the treatment of hepatopathy is characterized in that: it is to be made by the Chinese herbal medicine of following consumption proportion:
Radix Codonopsis 260-350 gram, GUANG Radix Notoginseng 50-120 gram, Rhizoma Atractylodis Macrocephalae (parched) 260-340 gram, PORIA from Yunnan of China 350-550 gram, Fructus Aurantii Immaturus (parched) 20-50 gram, Radix Aucklandiae 20-30 gram, Rhizoma dioscoreae 120-220 gram, Fructus Rubi 180-220 gram, Herba Sedi Sarmentosi 150-260 gram, Radix Isatidis 150-260 gram, Herba Taraxaci 100-220 gram, Radix Paeoniae Rubra 300-500 gram, Radix Paeoniae Alba (parched) 250-300 gram, Radix Bupleuri 40-60 gram.
2, according to the Chinese medicine of the described treatment hepatopathy of claim 1, it is characterized in that: it is to be made by the Chinese herbal medicine of following consumption proportion:
Radix codonopsis pilosulae's 300 grams, GUANG Radix Notoginseng 100 grams, Rhizoma Atractylodis Macrocephalae (parched) 300 grams, PORIA from Yunnan of China 500 grams, Fructus Aurantii Immaturus (parched) 50 grams, the Radix Aucklandiae 30 grams, Rhizoma dioscoreae 200 grams, Fructus Rubi 200 grams, Herba Sedi Sarmentosi 200 grams, Radix Isatidis 200 grams, Herba Taraxaci 200 grams, Radix Paeoniae Rubra 400 grams, Radix Paeoniae Alba (parched) 300 grams, Radix Bupleuri 60 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100415335A CN100342894C (en) | 2005-08-16 | 2005-08-16 | A Chinese medicine for treating liver disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100415335A CN100342894C (en) | 2005-08-16 | 2005-08-16 | A Chinese medicine for treating liver disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1879781A CN1879781A (en) | 2006-12-20 |
| CN100342894C true CN100342894C (en) | 2007-10-17 |
Family
ID=37518282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100415335A Expired - Fee Related CN100342894C (en) | 2005-08-16 | 2005-08-16 | A Chinese medicine for treating liver disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100342894C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102341114A (en) | 2009-03-03 | 2012-02-01 | 加拿大瑞发生物科技制药集团 | Herbal extract composition for prevention and treatment of influenza |
| CN102727633B (en) * | 2012-07-20 | 2014-03-19 | 成都中医药大学 | Pharmaceutical composition for treating chronic hepatitis B and preparation method and application thereof |
| CN106068667B (en) | 2015-07-13 | 2019-09-10 | 海能达通信股份有限公司 | A kind of LTE group system identical networking resource regulating method and device |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1113779A (en) * | 1994-06-17 | 1995-12-27 | 殷广全 | Anti- hepatitis B preparation |
| CN1137383A (en) * | 1995-06-02 | 1996-12-11 | 丁殿利 | Yigan Kangyangsan powder for curing hepatitis B |
| CN1253013A (en) * | 1999-10-25 | 2000-05-17 | 车兴泉 | Medicine for treating hepatism and its preparing process |
-
2005
- 2005-08-16 CN CNB2005100415335A patent/CN100342894C/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1113779A (en) * | 1994-06-17 | 1995-12-27 | 殷广全 | Anti- hepatitis B preparation |
| CN1137383A (en) * | 1995-06-02 | 1996-12-11 | 丁殿利 | Yigan Kangyangsan powder for curing hepatitis B |
| CN1253013A (en) * | 1999-10-25 | 2000-05-17 | 车兴泉 | Medicine for treating hepatism and its preparing process |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1879781A (en) | 2006-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103301412A (en) | Traditional Chinese medicine composition for treating alcoholic liver | |
| US7005146B2 (en) | Complex prescription of chinese medicine for the treatment of extensive cancer | |
| CN102205108B (en) | Traditional Chinese medicine preparation for treating gastric ulcer and preparation method thereof | |
| CN1270765C (en) | Medicinal wine or liquid for treating cold | |
| CN101116715A (en) | Chinese patent drug for treating non-gonococcal urethritis | |
| CN102847061B (en) | Traditional Chinese medicine preparation for treating pediatric viral myocarditis and preparation method thereof | |
| CN104873826A (en) | Tea drink capable of clearing away lung heat and dispelling damp and preparation method thereof | |
| CN100342894C (en) | A Chinese medicine for treating liver disease | |
| CN1067566C (en) | Chinese prescription medicine for treatment of digestive tract tumour and preparation method thereof | |
| CN101095780A (en) | Chinese traditional medicine preparations for treating diabetes fatty liver | |
| CN103393986B (en) | Traditional Chinese medicine composition for treating hepatitis b cirrhosis and preparation method thereof | |
| CN104940718A (en) | Pharmaceutical composition for treatment of chronic cholecystitis and preparation method thereof | |
| CN104547313A (en) | Medicine for treating lung cancer, breast cancer and lymph cancer and preparation method thereof | |
| CN101623493B (en) | Herba artemisiae scopariae turtle shell soup for treating cirrhosis | |
| CN105031595A (en) | Traditional Chinese medicine tablet for treating nummular eczema and preparing method thereof | |
| CN1336214A (en) | Traditional Chinese medicine for treating chronic bronchitis | |
| CN104083548A (en) | Traditional Chinese medicinal composition for treating ovarian cyst and preparation method thereof | |
| CN104306951A (en) | Traditional Chinese medicine combination for treating ascites of cirrhosis and preparing method of traditional Chinese medicine combination | |
| CN103463375B (en) | Traditional Chinese medicine composition for treating chronic type viral hepatitis B | |
| CN107961334A (en) | Treat the herbal composite of chronic pharyngitis | |
| CN101190317A (en) | Compound carapax trionycis capsule for expelling toxin, softening liver and becoming yin | |
| CN101116717A (en) | Chinese medicine preparation for treating non-gonococcal urethritis | |
| CN105169277A (en) | Fructus gardeniae oral liquid capable of protecting liver and benefiting gallbladder and preparation method thereof | |
| CN105878796A (en) | Vinegar beverage capable of treating type-II diabetes mellitus complicated with dyslipidemia and preparation method of vinegar beverage | |
| CN105250938A (en) | Drug for damp-heat type cirrhotic ascites |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20071017 Termination date: 20120816 |